Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$116,661,701
+$28,814,522 QoQ
Shares Held
4,535,836
-0.9% QoQ
Ownership
2.84%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,385 across 370 Biotechnology names. DNLI ranks #89 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,661,701 | 4,535,836 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $87,847,179 | 4,575,374 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $100,664,951 | 6,097,211 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $92,061,387 | 6,340,316 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $105,463,164 | 7,538,468 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $100,784,546 | 7,413,354 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $163,442,422 | 8,019,746 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $228,128,038 | 7,831,378 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,453,680 | 234,870 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $25,291,350 | 1,232,522 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $13,769,871 | 641,653 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $21,836,791 | 1,058,497 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $31,866,579 | 1,079,857 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $25,195,713 | 1,093,564 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $61,565,610 | 2,213,794 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $75,265,874 | 2,452,456 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $84,456,447 | 2,869,740 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $94,710,247 | 2,944,055 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $131,649,877 | 2,951,791 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $134,991,535 | 2,675,749 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $209,362,869 | 2,669,083 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $153,467,668 | 2,687,700 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $294,350,144 | 3,514,209 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $174,544,697 | 4,871,468 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $116,405,300 | 4,814,115 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $91,501,480 | 5,225,670 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||